Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Imjudo (Tremelimumab) Medicine in India

Buy Imjudo (Tremelimumab) Medicine in India

Imjudo (Tremelimumab)

Medicine name : Imjudo

Generic name : Tremelimumab

Manufactured By : Astra Zeneca

Indications : mNSCLC with no EGFR,ALK +VE Mutations

Medicine Description : Imjudo is a CTLA-4 inhibitor used in combination with other immunotherapies for advanced liver and lung cancers. It boosts the immune response against tumors. Given via IV infusion, it enhances long-term survival. Side effects include immune-related colitis, hepatitis, and pneumonitis. Careful immune-related side effect monitoring is essential for patient safety.

Product Introduction

Imjudo (Tremelimumab) is an immunotherapy medicine used in combination with other anticancer treatments for certain adults with unresectable or advanced hepatocellular carcinoma (HCC), a type of liver cancer. It is a monoclonal antibody that helps activate the body's immune system so it can recognize and attack cancer cells, helping to slow cancer growth and disease progression.

Imjudo (Tremelimumab) is administered by a healthcare professional through an intravenous infusion. The dose and treatment schedule are determined by your doctor based on your condition and the combination of medicines being used. It is given according to a specific treatment schedule and requires regular medical monitoring during therapy.

Common side effects of Imjudo may include fatigue, rash, diarrhea, itching, nausea, decreased appetite, abdominal pain, and cough. Because it activates the immune system, it can also cause immune-related reactions affecting organs such as the liver, lungs, intestines, kidneys, or thyroid. Inform your doctor promptly if you develop severe diarrhea, breathing difficulties, yellowing of the skin or eyes, significant changes in urination, or other unusual symptoms.

Uses Of Imjudo (Tremelimumab)

Treatment of Advanced Liver Cancer

Benefits Of Imjudo

Imjudo (Tremelimumab) is used in combination with durvalumab to treat certain adults with unresectable or advanced hepatocellular carcinoma (HCC), the most common type of primary liver cancer. It helps activate the immune system by blocking CTLA-4, allowing immune cells to better recognize and attack cancer cells. This can help slow cancer growth and disease progression and may improve overall survival in eligible patients.

Side Effects Of Imjudo (Tremelimumab)

Some side effects of Imjudo (Tremelimumab) may improve as your body adjusts to the medicine. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Imjudo (Tremelimumab)

  • Fatigue
  • Rash
  • Diarrhea
  • Itching
  • Nausea
  • Decreased appetite
  • Abdominal pain
  • Cough
  • Fever
  • Muscle or joint pain
How To Use Imjudo

Imjudo (Tremelimumab) is administered by a healthcare professional through an intravenous infusion. It is usually given in combination with durvalumab according to a specific treatment schedule prescribed by your doctor. The dose and duration depend on your condition and treatment plan. Regular medical check-ups and laboratory tests are required to monitor your response and detect possible side effects.

How Imjudo (Tremelimumab) Works

Imjudo (Tremelimumab) is an immunotherapy medicine that blocks a protein called CTLA-4, which normally limits the activity of T-cells. By blocking CTLA-4, Tremelimumab helps activate T-cells so they can better recognize and attack cancer cells. This immune response helps reduce cancer cell growth and may slow the progression of advanced hepatocellular carcinoma (HCC).

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Imjudo (Tremelimumab).

PregnancyCONSULT YOUR DOCTOR

Imjudo (Tremelimumab) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception as advised by your doctor.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment with Imjudo (Tremelimumab) and for the recommended period after the final dose. Consult your doctor for guidance.

DrivingCONSULT YOUR DOCTOR

Imjudo may cause fatigue, dizziness, or other effects that can affect your ability to drive. Avoid driving if these symptoms affect your alertness.

KidneyCAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor may monitor kidney function during therapy.

LiverCAUTION

Tell your doctor if you have liver problems. Since Imjudo can cause immune-related liver inflammation, your doctor may regularly monitor liver function during treatment.

Quick Tips
  • Attend all scheduled Imjudo (Tremelimumab) infusions and follow your doctor's treatment schedule carefully.
  • Report diarrhea, abdominal pain, or changes in bowel habits promptly, as these may indicate immune-related inflammation.
  • Contact your doctor immediately if you develop yellowing of the skin or eyes, dark urine, severe abdominal pain, or unusual tiredness.
  • Report new or worsening cough, breathing difficulties, severe rash, reduced urination, or significant changes in energy levels.
  • Attend regular blood tests and medical check-ups to monitor liver, kidney, thyroid, and other organ functions during treatment.
  • Read More About - Imjudo (Tremelimumab) from Pharma Five.
Faq

General Question

Imjudo Medicine (Tremelimumab) is a prescription drug used to treat certain types of cancer, including liver cancer (HCC) and non-small cell lung cancer (NSCLC), often in combination with other therapies.

Imjudo Medicine is a monoclonal antibody that targets CTLA-4, a protein that helps regulate the immune system. By blocking CTLA-4, Imjudo enhances the bodys immune response to fight cancer cells.

Doctors prescribe Imjudo Medicine for adults with advanced liver cancer (HCC) or NSCLC, typically in combination with durvalumab or other immunotherapy drugs.

Imjudo Medicine is given as an intravenous (IV) infusion by a healthcare professional, usually in a hospital or clinic setting.

Common side effects of Imjudo Medicine include fatigue, diarrhea, nausea, itching, rash, fever, and decreased appetite.

Yes, Imjudo Medicine may cause serious immune-related side effects affecting the lungs, liver, intestines, or endocrine system. Contact your doctor if you experience severe symptoms.

Imjudo Medicine is usually given in a fixed number of doses as part of a treatment plan. Your doctor will determine the duration based on your response to treatment.

It is best to avoid alcohol while taking Imjudo Medicine, as it may worsen liver-related side effects.

No, Imjudo Medicine may harm an unborn baby. Women should use effective contraception while receiving treatment and for some time afterward.

Yes, Imjudo Medicine may interact with other drugs, especially immunosuppressants or corticosteroids. Inform your doctor about all medications you are taking.

If you miss an infusion appointment, contact your doctor immediately to reschedule as soon as possible.

Since Imjudo Medicine is given as an IV infusion, food intake does not directly affect its administration. However, maintaining a balanced diet can help support overall health during treatment.

Monitor for signs of immune-related side effects, avoid live vaccines, and ensure regular check-ups to track your bodys response to treatment.

Imjudo Medicine is stored in a medical facility under controlled conditions and should not be stored at home.

Imjudo Medicine is available by prescription and administered in hospitals or specialized treatment centers. Consult your doctor for access to the medication. Pharma Five assists in its procurement.